The case for MDMA’s approval is riddled with problems

The FDA is considering approving MDMA alongside psychotherapy as a treatment for PTSD. But evidence of the drug’s effectiveness isn’t clear cut. Emily Mullin investigates the trial data and potential biases surrounding the case. Read by Emily Woo Zeller.